Where can I find news about ANEW?

The latest press releases, SEC filings, and earnings call transcripts for ProShares - MSCI Transformational Changes ETF (ANEW) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.

Where are ANEW's SEC filings?

ProShares - MSCI Transformational Changes ETF (ANEW)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

When was ANEW's last earnings call?

The most recent earnings call transcript for ProShares - MSCI Transformational Changes ETF (ANEW) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

ANEW

ProShares - MSCI Transformational Changes ETF

AMEX·Asset Management · Financial Services

$50.40$0.00+0.00%

After hours·$50.41+0.01%

Market cap$7.64M·Market closed·Jul 24 1:46 PM UTC

Press Releases

AI's Biggest Gainers
AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting the income statement (at least yet) for most companies.
seekingalpha.comJul 21, 2026 · 11:35 AM
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
Strategic Rebranding Reflects Focus on Neurodegenerative Therapies and Healthy Longevity New York, NY, September 17, 2024 – PRISM MediaWire – The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today announced a name and ticker symbol change to Klotho Neurosciences, Inc. (NASDAQ: KLTO), and has launched a new website, www.klothoneuro.com.
prismmediawire.comSep 17, 2024 · 6:30 AM
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Board of ANEW MEDICAL, INC.
globenewswire.comSep 17, 2024 · 6:30 AM
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 – PRISM MediaWire – ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it has two distinct goals for its pioneering cell and gene therapy development.
prismmediawire.comSep 4, 2024 · 7:47 AM
Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC.
globenewswire.comSep 4, 2024 · 7:46 AM
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors.
prismmediawire.comAug 26, 2024 · 5:01 AM
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors.
globenewswire.comAug 26, 2024 · 5:00 AM
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
New York, NY. August 21, 2024 – ANEW MEDICAL, INC.
prismmediawire.comAug 21, 2024 · 5:04 AM

SEC Filings

485APOS
Jul 24, 2026View on SEC
485APOS
Jul 24, 2026View on SEC
485APOS
Jul 24, 2026View on SEC
485APOS
Jul 24, 2026View on SEC
485APOS
Jul 24, 2026View on SEC
485APOS
Jul 24, 2026View on SEC

Transcripts

PRO

Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.

Click below to see what's inside, then upgrade to read every transcript for ANEW and 80,000+ other tickers.

Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.

Frequently Asked Questions About ANEW

Where can I find news about ANEW?: The latest press releases, SEC filings, and earnings call transcripts for ProShares - MSCI Transformational Changes ETF (ANEW) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.
Where are ANEW's SEC filings?: ProShares - MSCI Transformational Changes ETF (ANEW)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
When was ANEW's last earnings call?: The most recent earnings call transcript for ProShares - MSCI Transformational Changes ETF (ANEW) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

ProShares - MSCI Transformational Changes ETF

Frequently Asked Questions About ANEW

ProShares - MSCI Transformational Changes ETF

AI's Biggest Gainers

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy

Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

Frequently Asked Questions About ANEW

AI's Biggest Gainers

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy

Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)